PLASMA NEUROPEPTIDE-Y OF CHILDREN WITH NEUROBLASTOMA IN RELATION TO STAGE, AGE AND PROGNOSIS, AND TISSUE NEUROPEPTIDE-Y

Citation
J. Dotsch et al., PLASMA NEUROPEPTIDE-Y OF CHILDREN WITH NEUROBLASTOMA IN RELATION TO STAGE, AGE AND PROGNOSIS, AND TISSUE NEUROPEPTIDE-Y, Regulatory peptides, 75-6, 1998, pp. 185-190
Citations number
19
Categorie Soggetti
Endocrynology & Metabolism",Physiology
Journal title
ISSN journal
01670115
Volume
75-6
Year of publication
1998
Pages
185 - 190
Database
ISI
SICI code
0167-0115(1998)75-6:<185:PNOCWN>2.0.ZU;2-J
Abstract
The objective of this study was to relate plasma neuropeptide Y (NPY) concentrations of patients with neuroblastoma with the stage of the di sease, the patients' age, the prognosis, the tumor mRNA expression and with the effect on tumor cell proliferation. Plasma NPY of 85 patient s with neuroblastoma was measured by radioimmunoassay. The patients' m edian age was 18 months (range, three weeks-12 years). Ten children wi th childhood tumors that did not affect neurological or neuroendocrine structures and ten healthy children served as control groups. NPY mRN A expression in neuroblastoma tissue was assessed by Northern blot ana lysis. Proliferation of neuroblastoma cells (SK-N-MC and CHP 234) was evaluated by 5-bromo-2'-deoxyuridine incorporation during DNA synthesi s in vitro. Plasma NPY levels were significantly higher in stage 3 (p < 0.05), 4 (p < 0.001) and 4S (p < 0.05) patients than in both control groups. Plasma levels above 8 pmol/l were only seen in stages 2 (17%) , 3 (32%), 4 (45%) and 4S (44%). Seven of the 12 patients (58%) who di ed had NPY levels above 8 pmol/l (vs. 29% in survivors; p = 0.05). In patients with longer follow-up monitoring, relapse coincided with incr easing NPY levels. There was no relationship between the patients' age and their plasma NPY concentrations (r = 0.08; p = 0.49). No relation was found between NPY mRNA expression in tumor tissue and NPY plasma concentrations of the ten patients (r = 0.08; p = 0.81). NPY in the su pernatant of neuroblastoma cells did not alter the 5-bromo-2'-deoxyuri dine incorporation during DNA synthesis. In summary, NPY plasma concen trations in patients with neuroblastoma relate to the stage of the dis ease. The relation to the prognosis is at the threshold of significanc e. No relation between tissue and plasma NPY, nor any effect of NPY on proliferation of tumor cells was found. (C) 1998 Elsevier Science B.V . All rights reserved.